Utah Medical Products, Inc. (UTMD) Stock Forecast & Price Target

Utah Medical Products, Inc. (UTMD) has an ST Score of 61.3 out of 100, an overall grade of B. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Our own ST Score grades it B (61.3/100). This is data, not investment advice — always do your own research.

Utah Medical Products, Inc. (UTMD) earns a valuation grade of C-, measured against Medical - Instruments & Supplies peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

Utah Medical Products, Inc. (UTMD) earns a growth grade of D+, measured against Medical - Instruments & Supplies peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

Utah Medical Products, Inc. (UTMD) earns a profitability grade of A, measured against Medical - Instruments & Supplies peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

Utah Medical Products, Inc. (UTMD) earns a financial strength grade of A-, measured against Medical - Instruments & Supplies peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

Utah Medical Products, Inc. (UTMD) has a Piotroski F-Score of 7 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.